• Oligodendrocytes in health and disease
   
• Molecular Neuropathology of AT/RT and other SMARCB1- and SMARCA4-deficient Tumors
   
• Special model: Induced pluripotent stem cells
   
• Special method: Metagenomic sequencing
   

Our research is funded by DFG (German Research Council), Dr. Mildred Scheel Foundation for Cancer Research, Hertie Foundation, Wilhelm Sander Foundation, Friedrich-Wilhelm Hauss-Lipperheide Foundation, Innovative Medical Research (IMF) and Rolf-Dierichs-Foundation